Figure 3. Survival of patients treated for recurrent leukemia and multiple myeloma after allogeneic stem cell transplantation with DLT. • indicates CML (N = 257); ▿, myeloma (N = 30); –, AML/MDS; ▴, ALL, DLT, donor lymphocyte transfusions; and N, number of patients studied.
Figure 3.

Survival of patients treated for recurrent leukemia and multiple myeloma after allogeneic stem cell transplantation with DLT. • indicates CML (N = 257); ▿, myeloma (N = 30); –, AML/MDS; ▴, ALL, DLT, donor lymphocyte transfusions; and N, number of patients studied.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal